Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Gardasil HPV Vaccine Lawsuit Side effects of the Gardasil HPV vaccine have been linked to reports of serious and debilitating autoimmune injuries. Lawyers review cases nationwide.
Fresenius Hemodialysis Machine Recall Issued Due to Toxic Compound Exposure Risks FDA officials warn certain recalled Fresenius hemodialysis machines can leak toxic compounds into the bloodstream for up to a month after the devices are first put into service, posing serious and deadly risks to patients. October 25, 2023 Katherine McDaniel Add Your Comments A recall has been issued for certain Fresenius hemodialysis machines, due to a risk that the devices may release toxic compounds into a patient’s bloodstream, which can result in serious health consequences. The U.S. Food and Drug Administration (FDA) announced the Fresenius hemodialysis machine recall on October 24, indicating that the machines had tubing held together with silicone materials that contains toxic chemicals, which may release from within the machine and enter the patient’s bloodstream during treatment. The machines are used to treat patients suffering from kidney injuries or kidney disease, by filtering the blood from waste, toxins, and excess fluids. However, the FDA indicates the silicone materials may leach from the dialysis tubes and expose patients to harmful chemicals, including non-dioxin-like (NDL) polychlorinated biphenyl acids (PCBAs). The chemicals are chlorine compounds commonly used as technical mixtures in building materials and electrical equipment, which can cause liver problems, endocrine dysfunction, neurobehavioral changes, skin rashes or acne, and even male infertility months to years after exposure. Fresenius Hemodialysis Machine Toxic Exposure Investigation Federal health officials first issued a letter to healthcare professionals on May 6, 2022, warning that silicone tubing in certain 2008T, 2008K2, and 2008K models may present risks of NDL PCBAs and NDL polychlorinated biphenyls (PCBs) exposure to patients, and initiated an investigation into the issue. The agency indicated that the devices could release toxic compounds into the bloodstream, posing serious health risks to those receiving treatment for severe kidney injuries or disease. The FDA recommended healthcare professionals continue providing treatments as necessary, and to consider using an alternative machine, if possible, while the agency and manufacturer investigated the degree and duration of the potential toxin exposure. In March 2023, the FDA advised that the source of the NDL PCBAs and NDL PCBs stemmed from the chlorinated peroxide initiator used to manufacture the silicone tubing, and the manufacturer modified the silicone tubing to correct the issue. The toxins were not detected in the machines after the new platinum silicone tubing was implemented, prompting the agency to issue a recall this month to correct the machines with the updated material. Fresenius Hemodialysis Machine Recall While it is considered a product correction and not a product removal, the FDA has given the Fresenius hemodialysis machine recall a Class I designation, warning healthcare professionals that patients face an increased risk of sustaining serious injuries or death if they continue using the devices. Fresenius Medical Care indicated that the amount of NDL PCBAs released by the machines decreased over the first month of routine clinical use. However, devices manufactured between August 21, 2008 and June 6, 2022 that were used for less than 36 days (486 hours) may still expose patients to harmful toxins and need updated silicone tubing to correct the issue. To date, the agency is not aware of any injuries or deaths linked to the hemodialysis machines toxic compound exposures. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The recall impacts approximately 207 Fresenius Medical Care 2008 Series Hemodialysis Machines distributed from August 21, 2008 until June 6, 2022 that require correction, and includes the following models: 2008T HD SYS. W/O CDX BLUESTAR 2008T HD SYS. CDX W/BIBAG BLUESTAR 2008T HD SYS. CDX BLUESTAR 2008T HD SYS. W/O CDX W/BIBAG BLUESTAR 2008T Hemodialysis SYS, with CDX 2008T Hemodialysis System without CDX 2008T Hemodialysis System w/Bibag 2008T GEN 2 Bibag without CDX Fresenius Medical Care issued an urgent medical device correction letter to customers on September 26, instructing those with machines containing chlorinated peroxide cured silicone tubing used for less than 36 days (486 hours) to contact the manufacturer for free. updated, platinum cured silicone tubing. It also indicated that new machines purchased after October 2022 were manufactured with the new silicone tubing, and do not require correction. For more information on the recall, or to schedule an appointment to receive the updated tubing, customers may contact Fresenius Medical Care customer service by phone at 1-800-227-2572. Consumers are urged to report any problems they experienced after using the recalled hemodialysis machines to the FDA MedWatch Adverse Event Reporting program. Tags: Chemicals, Fresenius, Hemodialysis, Kidney Failure, Medical Device Recall, Toxicity More Lawsuit Stories Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 March 14, 2025 At Least 8 Lawsuits Over Oxbryta Filed Against Pfizer, Global Blood Therapeutics March 14, 2025 Judge Calls for Change Healthcare Data Breach Lawsuits in State and Federal Courts To Be Coordinated March 14, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (Posted: today) Parties involved in Covidien hernia mesh lawsuits indicate they are ready to meet with a mediator in a couple weeks to begin potential settlement negotiations. MORE ABOUT: HERNIA MESH LAWSUITCovidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025)Discovery Deadlines in Covidien Hernia Mesh Lawsuits Extended by MDL Judge (12/12/2024)Court Appoints Bard Hernia Mesh Settlement Special Masters To Implement “Intensive” Process To Resolve Claims (11/22/2024) Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (Posted: yesterday) A federal judge has outlined the schedule for preparing a group of hair relaxer lawsuits for early bellwether trials, which will not go before a jury until at least 2027. MORE ABOUT: HAIR RELAXER LAWSUITSynthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)Hair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025) Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (Posted: 2 days ago) A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications. MORE ABOUT: BIOZORB LAWSUITBioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)
Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 March 14, 2025
Judge Calls for Change Healthcare Data Breach Lawsuits in State and Federal Courts To Be Coordinated March 14, 2025
Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (Posted: today) Parties involved in Covidien hernia mesh lawsuits indicate they are ready to meet with a mediator in a couple weeks to begin potential settlement negotiations. MORE ABOUT: HERNIA MESH LAWSUITCovidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025)Discovery Deadlines in Covidien Hernia Mesh Lawsuits Extended by MDL Judge (12/12/2024)Court Appoints Bard Hernia Mesh Settlement Special Masters To Implement “Intensive” Process To Resolve Claims (11/22/2024)
Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (Posted: yesterday) A federal judge has outlined the schedule for preparing a group of hair relaxer lawsuits for early bellwether trials, which will not go before a jury until at least 2027. MORE ABOUT: HAIR RELAXER LAWSUITSynthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)Hair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025)
Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (Posted: 2 days ago) A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications. MORE ABOUT: BIOZORB LAWSUITBioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)